Pluri (PLUR) Times Interest Earned (2011 - 2025)
Pluri (PLUR) posted quarterly Times Interest Earned of -$28.16 for Q4 2025, down 19.89% year-over-year from -$35.16 in Q4 2024, and down 1.57% quarter-over-quarter from -$27.73 in Q3 2025.
Pluri (PLUR) Times Interest Earned (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Times Interest Earned for 15 consecutive years, with -$28.16 the latest figure, recorded in Q4 2025.
- In Q4 2025, Times Interest Earned fell 19.89% year-over-year to -$28.16; the TTM figure through Dec 2025 stood at -$27.49 (down 9.08% YoY), while the FY2025 annual figure was -$0.31, up 98.8% from the prior year.
- Times Interest Earned retreated to -$28.16 in Q4 2025 per PLUR's latest filing, from -$27.73 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$9.16 in Q2 2022 and bottomed at -$92.32 in Q2 2021.
- Historically, Times Interest Earned has averaged -$34.97 across 5 years, with a median of -$28.29 in 2025.
- Annual changes were most pronounced in 2022 — Times Interest Earned soared 90.08% — and 2023, when it tumbled 224.85%.
- Pluri's Times Interest Earned stood at -$47.98 in 2021, then soared by 34.33% to -$31.5 in 2022, then advanced by 23.39% to -$24.13 in 2023, then increased by 2.66% to -$23.49 in 2024, then declined by 19.89% to -$28.16 in 2025.
- Business Quant data shows PLUR's Times Interest Earned at -$28.16 in Q4 2025, -$27.73 in Q3 2025, and -$28.42 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | -28.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.16 |
| Sep 30, 2025 | -27.73 |
| Jun 30, 2025 | -28.42 |
| Mar 31, 2025 | -25.47 |
| Dec 31, 2024 | -23.49 |
| Sep 30, 2024 | -23.95 |
| Jun 30, 2024 | -27.68 |
| Mar 31, 2024 | -14.19 |
| Dec 31, 2023 | -24.13 |
| Sep 30, 2023 | -25.13 |
| Jun 30, 2023 | -29.75 |
| Mar 31, 2023 | -32.72 |
| Dec 31, 2022 | -31.50 |
| Sep 30, 2022 | -35.69 |
| Jun 30, 2022 | -9.16 |
| Mar 31, 2022 | -46.97 |
| Dec 31, 2021 | -47.98 |
| Sep 30, 2021 | -50.18 |
| Jun 30, 2021 | -92.32 |
| Mar 31, 2021 | -74.87 |